Risks of Opioid Overdose Linked to Concurrent Use of Hydrocodone and SSRIs
By
Sungho Bea
Krista F. Huybrechts
Robert J. Glynn
Seanna M. Vine
Shruti Belitkar
Brian T. Bateman
Katsiaryna Bykov
November 28, 2025
Clinical Scorecard: Risks of Opioid Overdose Linked to Concurrent Use of Hydrocodone and SSRIs
At a Glance
Category Detail
Condition
Key Mechanisms
Target Population Adults aged 18 years or older initiating SSRI treatment while using hydrocodone, excluding those with prior opioid overdose.
Care Setting
Key Highlights
The study analyzed data from multiple US healthcare claims databases from 2004 to 2022, focusing on the comparative risk of overdose.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Individuals aged 18 years and older initiating SSRI treatment while on hydrocodone.
Patients should be carefully evaluated for the necessity of concurrent SSRI and opioid therapy.
Clinical Best Practices
Related Resources & Content